Top

Published in:

Open Access 01-12-2021 | Pancreatic Cancer | Research

Kaempferol induces ROS-dependent apoptosis in pancreatic cancer cells via TGM2-mediated Akt/mTOR signaling

Authors: Fengjiao Wang, Lai Wang, Chao Qu, Lianyu Chen, Yawen Geng, Chienshan Cheng, Shulin Yu, Dan Wang, Lina Yang, Zhiqiang Meng, Zhen Chen

Published in: BMC Cancer | Issue 1/2021

Abstract

Background

Kaempferol, a natural flavonoid, exhibits anticancer properties by scavenging reactive oxygen species (ROS). However, increasing evidence has demonstrated that, under certain conditions, kaempferol can inhibit tumor growth by upregulating ROS levels. In this study, we aimed to investigate whether kaempferol effectively suppresses pancreatic cancer through upregulation of ROS, and to explore the underlying molecular mechanism.

Methods

PANC-1 and Mia PaCa-2 cells were exposed to different concentrations of kaempferol. Cell proliferation and colony formation were evaluated by CCK-8 and colony formation assays. Flow cytometry was performed to assess the ROS levels and cell apoptosis. The mRNA sequencing and KEGG enrichment analysis were performed to identify differentially expressed genes and to reveal significantly enriched signaling pathways in response to kaempferol treatment. Based on biological analysis, we hypothesized that tissue transglutaminase (TGM2) gene was an essential target for kaempferol to induce ROS-related apoptosis in pancreatic cancer. TGM2 was overexpressed by lentivirus vector to verify the effect of TGM2 on the ROS-associated apoptotic signaling pathway. Western blot and qRT-PCR were used to determine the protein and mRNA levels, respectively. The prognostic value of TGM2 was analyzed by Gene Expression Profiling Interactive Analysis (GEPIA) tools based on public data from the TCGA database.

Results

Kaempferol effectively suppressed pancreatic cancer in vitro and in vivo. Kaempferol promoted apoptosis in vitro by increasing ROS generation, which was involved in Akt/mTOR signaling. TGM2 levels were significantly increased in PDAC tissues compared with normal tissues, and high TGM2 expression was positively correlated with poor prognosis in pancreatic cancer patients. Decreased TGM2 mRNA and protein levels were observed in the cells after treatment with kaempferol. Additionally, TGM2 overexpression downregulated ROS production and inhibited the abovementioned apoptotic signaling pathway.

Conclusions

Kaempferol induces ROS-dependent apoptosis in pancreatic cancer cells via TGM2-mediated Akt/mTOR signaling, and TGM2 may represent a promising prognostic biomarker for pancreatic cancer.

Siegel RL, Miller KD, Jemal A. Cancer statistics, 2018. CA Cancer J Clin. 2018;68(1):7–30. https://doi.org/10.3322/caac.21442.CrossRefPubMed

The Lancet Gastroenterology H. Pancreatic cancer: how can we tackle the lack of progress? Lancet Gastroenterol Hepatol. 2017;2(2):73.CrossRef

Neoptolemos JP, Kleeff J, Michl P, Costello E, Greenhalf W, Palmer DH. Therapeutic developments in pancreatic cancer: current and future perspectives. Nat Rev Gastroenterol Hepatol. 2018;15(6):333–48. https://doi.org/10.1038/s41575-018-0005-x.CrossRefPubMed

Mittler R. ROS are good. Trends Plant Sci. 2017;22(1):11–9. https://doi.org/10.1016/j.tplants.2016.08.002.CrossRefPubMed

Schieber M, Chandel NS. ROS function in redox signaling and oxidative stress. Curr Biol. 2014;24(10):R453–62. https://doi.org/10.1016/j.cub.2014.03.034.CrossRefPubMedPubMedCentral

Le Belle JE, Orozco NM, Paucar AA, Saxe JP, Mottahedeh J, Pyle AD, et al. Proliferative neural stem cells have high endogenous ROS levels that regulate self-renewal and neurogenesis in a PI3K/Akt-dependant manner. Cell Stem Cell. 2011;8(1):59–71. https://doi.org/10.1016/j.stem.2010.11.028.CrossRefPubMedPubMedCentral

Moloney JN, Cotter TG. ROS signalling in the biology of cancer. Semin Cell Dev Biol. 2018;80:50–64. https://doi.org/10.1016/j.semcdb.2017.05.023.CrossRefPubMed

Sabharwal SS, Schumacker PT. Mitochondrial ROS in cancer: initiators, amplifiers or an Achilles' heel? Nat Rev Cancer. 2014;14(11):709–21. https://doi.org/10.1038/nrc3803.CrossRefPubMedPubMedCentral

Martinez-Useros J, Li W, Cabeza-Morales M, Garcia-Foncillas J. Oxidative Stress: A New Target for Pancreatic Cancer Prognosis and Treatment. J Clin Med. 2017;6(3):29. https://doi.org/10.3390/jcm6030029.

10.

Donadelli M, Dando I, Zaniboni T, Costanzo C, Dalla Pozza E, Scupoli MT, et al. Gemcitabine/cannabinoid combination triggers autophagy in pancreatic cancer cells through a ROS-mediated mechanism. Cell Death Dis. 2011;2(4):e152. https://doi.org/10.1038/cddis.2011.36.CrossRefPubMedPubMedCentral

11.

Moon DO, Kim MO, Choi YH, Hyun JW, Chang WY, Kim GY. Butein induces G(2)/M phase arrest and apoptosis in human hepatoma cancer cells through ROS generation. Cancer Lett. 2010;288(2):204–13. https://doi.org/10.1016/j.canlet.2009.07.002.CrossRefPubMed

12.

Maleki SJ, Crespo JF, Cabanillas B. Anti-inflammatory effects of flavonoids. Food Chem. 2019;299:125124. https://doi.org/10.1016/j.foodchem.2019.125124.CrossRefPubMed

13.

Zhao Y, Guo Q, Zhu Q, Tan R, Bai D, Bu X, et al. Flavonoid VI-16 protects against DSS-induced colitis by inhibiting Txnip-dependent NLRP3 inflammasome activation in macrophages via reducing oxidative stress. Mucosal Immunol. 2019;12(5):1150–63. https://doi.org/10.1038/s41385-019-0177-x.CrossRefPubMed

14.

Choi JB, Kim JH, Lee H, Pak JN, Shim BS, Kim SH. Reactive oxygen species and p53 mediated activation of p38 and Caspases is critically involved in Kaempferol induced apoptosis in colorectal Cancer cells. J Agric Food Chem. 2018;66(38):9960–7. https://doi.org/10.1021/acs.jafc.8b02656.CrossRefPubMed

15.

Liao W, Chen L, Ma X, Jiao R, Li X, Wang Y. Protective effects of kaempferol against reactive oxygen species-induced hemolysis and its antiproliferative activity on human cancer cells. Eur J Med Chem. 2016;114:24–32. https://doi.org/10.1016/j.ejmech.2016.02.045.CrossRefPubMed

16.

Sun ZL, Dong JL, Wu J. Juglanin induces apoptosis and autophagy in human breast cancer progression via ROS/JNK promotion. Biomed Pharmacother. 2017;85:303–12. https://doi.org/10.1016/j.biopha.2016.11.030.CrossRefPubMed

17.

Zhang Q, Cheng G, Qiu H, Zhu L, Ren Z, Zhao W, et al. The p53-inducible gene 3 involved in flavonoid-induced cytotoxicity through the reactive oxygen species-mediated mitochondrial apoptotic pathway in human hepatoma cells. Food Funct. 2015;6(5):1518–25. https://doi.org/10.1039/C5FO00142K.CrossRefPubMed

18.

Mortazavi A, Williams BA, McCue K, Schaeffer L, Wold B. Mapping and quantifying mammalian transcriptomes by RNA-Seq. Nat Methods. 2008;5(7):621–8. https://doi.org/10.1038/nmeth.1226.CrossRefPubMed

19.

Wang FJ, Wang P, Chen LY, Geng YW, Chen H, Meng ZQ, et al. TAM infiltration differences in "tumor-first" and " ZHENG-first" models and the underlying inflammatory molecular mechanism in pancreatic Cancer. Integr Cancer Ther. 2018;17(3):707–16. https://doi.org/10.1177/1534735418771193.CrossRefPubMedPubMedCentral

20.

Cheng X, Yang YL, Yang H, Wang YH, Du GH. Kaempferol alleviates LPS-induced neuroinflammation and BBB dysfunction in mice via inhibiting HMGB1 release and down-regulating TLR4/MyD88 pathway. Int Immunopharmacol. 2018;56:29–35. https://doi.org/10.1016/j.intimp.2018.01.002.CrossRefPubMed

21.

Luo C, Yang H, Tang C, Yao G, Kong L, He H, et al. Kaempferol alleviates insulin resistance via hepatic IKK/NF-κB signal in type 2 diabetic rats. Int Immunopharmacol. 2015;28(1):744–50. https://doi.org/10.1016/j.intimp.2015.07.018.CrossRefPubMed

22.

Wendel HG, De Stanchina E, Fridman JS, Malina A, Ray S, Kogan S, et al. Survival signalling by Akt and eIF4E in oncogenesis and cancer therapy. Nature. 2004;428(6980):332–7. https://doi.org/10.1038/nature02369.CrossRefPubMed

23.

Du W, An Y, He X, Zhang D, He W. Protection of Kaempferol on oxidative stress-induced retinal pigment epithelial cell damage. Oxidative Med Cell Longev. 2018;2018:1610751.CrossRef

24.

Chin HK, Horng CT, Liu YS, Lu CC, Su CY, Chen PS, et al. Kaempferol inhibits angiogenic ability by targeting VEGF receptor-2 and downregulating the PI3K/AKT, MEK and ERK pathways in VEGF-stimulated human umbilical vein endothelial cells. Oncol Rep. 2018;39(5):2351–7. https://doi.org/10.3892/or.2018.6312.CrossRefPubMed

25.

Bollong MJ, Lee G, Coukos JS, Yun H, Zambaldo C, Chang JW, et al. A metabolite-derived protein modification integrates glycolysis with KEAP1-NRF2 signalling. Nature. 2018;562(7728):600–4. https://doi.org/10.1038/s41586-018-0622-0.CrossRefPubMedPubMedCentral

26.

Yamamoto M, Kensler TW, Motohashi H. The KEAP1-NRF2 system: a Thiol-based sensor-effector apparatus for maintaining redox homeostasis. Physiol Rev. 2018;98(3):1169–203. https://doi.org/10.1152/physrev.00023.2017.CrossRefPubMed

27.

Qin JJ, Cheng XD, Zhang J, Zhang WD. Dual roles and therapeutic potential of Keap1-Nrf2 pathway in pancreatic cancer: a systematic review. Cell Commun Signal. 2019;17(1):121. https://doi.org/10.1186/s12964-019-0435-2.CrossRefPubMedPubMedCentral

28.

Zimmerman MC, Case AJ. Redox biology in physiology and disease. Redox Biol. 2019;27:101267. https://doi.org/10.1016/j.redox.2019.101267.CrossRefPubMedPubMedCentral

29.

Panieri E, Santoro MM. ROS homeostasis and metabolism: a dangerous liason in cancer cells. Cell Death Dis. 2016;7(6):e2253. https://doi.org/10.1038/cddis.2016.105.CrossRefPubMedPubMedCentral

30.

Alberghina L, Gaglio D. Redox control of glutamine utilization in cancer. Cell Death Dis. 2014;5(12):e1561. https://doi.org/10.1038/cddis.2014.513.CrossRefPubMedPubMedCentral

31.

Piskounova E, Agathocleous M, Murphy MM, Hu Z, Huddlestun SE, Zhao Z, et al. Oxidative stress inhibits distant metastasis by human melanoma cells. Nature. 2015;527(7577):186–91. https://doi.org/10.1038/nature15726.CrossRefPubMedPubMedCentral

32.

Liu X, Zhao P, Wang X, Wang L, Zhu Y, Gao W. Triptolide induces Glioma cell autophagy and apoptosis via Upregulating the ROS/JNK and Downregulating the Akt/mTOR signaling pathways. Front Oncol. 2019;9:387. https://doi.org/10.3389/fonc.2019.00387.CrossRefPubMedPubMedCentral

33.

Zhang Y, Kwok-Shing Ng P, Kucherlapati M, Chen F, Liu Y, Tsang YH, et al. A Pan-Cancer Proteogenomic Atlas of PI3K/AKT/mTOR Pathway Alterations. Cancer Cell. 2017;31(6):820–32 e823.CrossRefPubMedPubMedCentral

34.

Fiorini C, Cordani M, Gotte G, Picone D, Donadelli M. Onconase induces autophagy sensitizing pancreatic cancer cells to gemcitabine and activates Akt/mTOR pathway in a ROS-dependent manner. Biochim Biophys Acta. 2015;1853(3):549–60. https://doi.org/10.1016/j.bbamcr.2014.12.016.CrossRefPubMed

35.

Jian J, Xuan F, Qin F, Huang R. The antioxidant, anti-inflammatory and anti-apoptotic activities of the Bauhinia Championii flavone are connected with protection against myocardial ischemia/reperfusion injury. Cell Physiol Biochem. 2016;38(4):1365–75. https://doi.org/10.1159/000443080.CrossRefPubMed

36.

Tsuchiya S, Sugimoto K, Kamio H, Okabe K, Kuroda K, Okido M, et al. Kaempferol-immobilized titanium dioxide promotes formation of new bone: effects of loading methods on bone marrow stromal cell differentiation in vivo and in vitro. Int J Nanomedicine. 2018;13:1665–76. https://doi.org/10.2147/IJN.S150786.CrossRefPubMedPubMedCentral

37.

Wu P, Meng X, Zheng H, Zeng Q, Chen T, Wang W, et al. Kaempferol Attenuates ROS-Induced Hemolysis and the Molecular Mechanism of Its Induction of Apoptosis on Bladder Cancer. Molecules. 2018;23(10):2592. https://doi.org/10.3390/molecules23102592.

38.

Rajendran P, Rengarajan T, Nandakumar N, Palaniswami R, Nishigaki Y, Nishigaki I. Kaempferol, a potential cytostatic and cure for inflammatory disorders. Eur J Med Chem. 2014;86:103–12. https://doi.org/10.1016/j.ejmech.2014.08.011.CrossRefPubMed

39.

Lee CF, Yang JS, Tsai FJ, Chiang NN, Lu CC, Huang YS, et al. Kaempferol induces ATM/p53-mediated death receptor and mitochondrial apoptosis in human umbilical vein endothelial cells. Int J Oncol. 2016;48(5):2007–14. https://doi.org/10.3892/ijo.2016.3420.CrossRefPubMed

40.

Singh A, Daemen A, Nickles D, Jeon SM, Foreman O, Sudini K, et al. NRF2 activation promotes aggressive lung Cancer and associates with poor clinical outcomes. Clin Cancer Res. 2021;27(3):877–88. https://doi.org/10.1158/1078-0432.CCR-20-1985.CrossRefPubMed

41.

Xu Y, Yang Y, Huang Y, Ma Q, Shang J, Guo J, et al. Inhibition of Nrf2/HO-1 signaling pathway by dextran sulfate suppresses angiogenesis of gastric Cancer. J Cancer. 2021;12(4):1042–60. https://doi.org/10.7150/jca.50605.CrossRefPubMedPubMedCentral

42.

Wu S, Lu H, Bai Y. Nrf2 in cancers: a double-edged sword. Cancer Med. 2019;8(5):2252–67. https://doi.org/10.1002/cam4.2101.CrossRefPubMedPubMedCentral

43.

Eckert RL, Kaartinen MT, Nurminskaya M, Belkin AM, Colak G, Johnson GVW, et al. Transglutaminase regulation of cell function. Physiol Rev. 2014;94(2):383–417. https://doi.org/10.1152/physrev.00019.2013.CrossRefPubMedPubMedCentral

44.

Hernandez-Fernaud JR, Ruengeler E, Casazza A, Neilson LJ, Pulleine E, Santi A, et al. Secreted CLIC3 drives cancer progression through its glutathione-dependent oxidoreductase activity. Nat Commun. 2017;8(1):14206. https://doi.org/10.1038/ncomms14206.CrossRefPubMedPubMedCentral

45.

Torres A, Pac-Sosińska M, Wiktor K, Paszkowski T, Maciejewski R, Torres K. CD44, TGM2 and EpCAM as novel plasma markers in endometrial cancer diagnosis. BMC Cancer. 2019;19(1):401. https://doi.org/10.1186/s12885-019-5556-x.

46.

Zonca S, Pinton G, Wang Z, Soluri MF, Tavian D, Griffin M, et al. Tissue transglutaminase (TG2) enables survival of human malignant pleural mesothelioma cells in hypoxia. Cell Death Dis. 2017;8(2):e2592. https://doi.org/10.1038/cddis.2017.30.CrossRefPubMedPubMedCentral

47.

Gu C, Cai J, Xu Z, Zhou S, Ye L, Yan Q, et al. MiR-532-3p suppresses colorectal cancer progression by disrupting the ETS1/TGM2 axis-mediated Wnt/beta-catenin signaling. Cell Death Dis. 2019;10(10):739. https://doi.org/10.1038/s41419-019-1962-x.CrossRefPubMedPubMedCentral

48.

Zhang H, McCarty N. Tampering with cancer chemoresistance by targeting the TGM2-IL6-autophagy regulatory network. Autophagy. 2017;13(3):627–8. https://doi.org/10.1080/15548627.2016.1271516.CrossRefPubMedPubMedCentral

Title: Kaempferol induces ROS-dependent apoptosis in pancreatic cancer cells via TGM2-mediated Akt/mTOR signaling
Authors: Fengjiao Wang
Lai Wang
Chao Qu
Lianyu Chen
Yawen Geng
Chienshan Cheng
Shulin Yu
Dan Wang
Lina Yang
Zhiqiang Meng
Zhen Chen
Publication date: 01-12-2021
Publisher: BioMed Central
Keywords: Pancreatic Cancer
Pancreatic Cancer
Biomarkers
Published in: BMC Cancer / Issue 1/2021
Electronic ISSN: 1471-2407
DOI: https://doi.org/10.1186/s12885-021-08158-z

Webinar | 19-02-2024 | 17:30 (CET)

Keynote webinar | Spotlight on antibody–drug conjugates in cancer

Watch now

Antibody–drug conjugates (ADCs) are novel agents that have shown promise across multiple tumor types. Explore the current landscape of ADCs in breast and lung cancer with our experts, and gain insights into the mechanism of action, key clinical trials data, existing challenges, and future directions.

Dr. Véronique Diéras

Prof. Fabrice Barlesi

Developed by: Springer Medicine

Keynote webinar | Spotlight on medication adherence

Springer Medicine

Abstract

Background

Methods

Results

Conclusions

Please log in to get access to this content

Other articles of this Issue 1/2021

Exosomal microRNA-107 reverses chemotherapeutic drug resistance of gastric cancer cells through HMGA2/mTOR/P-gp pathway

Optimizing oropharyngeal cancer management by using proton beam therapy: trends of cost-effectiveness

Nomogram based on autophagy related genes for predicting the survival in melanoma

Cardiopulmonary-related patient-reported outcomes in a randomized clinical trial of radiation therapy for breast cancer

The association between protease inhibitors and anal cancer outcomes in veterans living with HIV treated with definitive chemoradiation: a retrospective study

Hsa_circ_0000301 facilitates the progression of cervical cancer by targeting miR-1228-3p/IRF4 Axis

Keynote webinar | Spotlight on antibody–drug conjugates in cancer